Eberhard Grube, MD, FSCAI

Head CIIC
University Hospital Bonn
Siegburg, Nordrhein-Westfalen, Germany

Eberhard Grube, MD, FACC, FACA, FSCA

Prof. Grube is Professor of Medicine, Head, Center of Innovative Interventions in Cardiology (CIIC) University Hospital Bonn, Germany and Consulting Professor, Division of Cardiovascular Medicine, at Stanford University School of Medicine.
He received his first degree in Medicine at the Rheinische Friedrich-Wilhelm-University in Bonn. His cardiology training was completed at University of Wisconsin, Medical School and University of Bonn, Medical School.
He received his Board Certification in Internal Medicine, in Cardiology and in Angiology from the North Rhine Chamber of Medical Doctors and his post-doctoral lecturing qualification “Internal Medicine“ from the Rheinische Friedrich-Wilhelm-University in Bonn.
He is a fellow of the American College of Cardiology, the American College of Angiology and the Society for Cardiac Angiography & Interventions.

Presentation(s):

• CARDIOTUBE INTERIVEW: Lifetime management of TAVR

  Sunday, February 26, 2023
  3:00 PM – 3:10 PM ET

  Disclosure information not submitted.

• Hot Topics in Structural

  Monday, February 27, 2023
  8:00 AM – 11:30 AM ET

  Disclosure(s): Ancora: Equity Interest (Ongoing); Boston Scientific: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); CardioMech: Equity Interest (Ongoing); Cardiovalve: Equity Interest (Ongoing); Claret: Equity Interest (Ongoing); HighLife: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Imperative Care: Equity Interest (Ongoing); Jena Valve: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Laminar: Equity Interest (Ongoing); Medtronic: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Millipede: Equity Interest (Ongoing); Pi-Cardia: Equity Interest (Ongoing); Protembis: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Reniva Medical: Equity Interest (Ongoing); Shockwave: Equity Interest (Ongoing); Valve medical: Equity Interest (Ongoing)

• Live Case from Medizinische Klinik, St. Johannes Hospital Dortmund | Dortmund, Germany

  Monday, February 27, 2023
  8:55 AM – 9:40 AM ET

  Disclosure(s): Ancora: Equity Interest (Ongoing); Boston Scientific: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); CardioMech: Equity Interest (Ongoing); Cardiovalve: Equity Interest (Ongoing); Claret: Equity Interest (Ongoing); HighLife: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Imperative Care: Equity Interest (Ongoing); Jena Valve: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Laminar: Equity Interest (Ongoing); Medtronic: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Millipede: Equity Interest (Ongoing); Pi-Cardia: Equity Interest (Ongoing); Protembis: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Reniva Medical: Equity Interest (Ongoing); Shockwave: Equity Interest (Ongoing); Valve medical: Equity Interest (Ongoing)

• TAVR: State of the Field - What is Next for TAVR…Asymptomatic, Moderate AS or Severe AR?

  Monday, February 27, 2023
  9:40 AM – 9:50 AM ET

  Disclosure(s): Ancora: Equity Interest (Ongoing); Boston Scientific: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); CardioMech: Equity Interest (Ongoing); Cardiovalve: Equity Interest (Ongoing); Claret: Equity Interest (Ongoing); HighLife: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Imperative Care: Equity Interest (Ongoing); Jena Valve: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Laminar: Equity Interest (Ongoing); Medtronic: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Millipede: Equity Interest (Ongoing); Pi-Cardia: Equity Interest (Ongoing); Protembis: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Reniva Medical: Equity Interest (Ongoing); Shockwave: Equity Interest (Ongoing); Valve medical: Equity Interest (Ongoing)

• Power Break Symposium: Live Case from Tucson Medical Center | Tucson, AZ (Non-CME)

  Monday, February 27, 2023
  12:45 PM – 1:30 PM ET

  Disclosure(s): Ancora: Equity Interest (Ongoing); Boston Scientific: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); CardioMech: Equity Interest (Ongoing); Cardiovalve: Equity Interest (Ongoing); Claret: Equity Interest (Ongoing); HighLife: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Imperative Care: Equity Interest (Ongoing); Jena Valve: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Laminar: Equity Interest (Ongoing); Medtronic: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Millipede: Equity Interest (Ongoing); Pi-Cardia: Equity Interest (Ongoing); Protembis: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Reniva Medical: Equity Interest (Ongoing); Shockwave: Equity Interest (Ongoing); Valve medical: Equity Interest (Ongoing)

• Valve Aortic (Non-CME)

  Monday, February 27, 2023
  1:30 PM – 5:45 PM ET

  Disclosure(s): Ancora: Equity Interest (Ongoing); Boston Scientific: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); CardioMech: Equity Interest (Ongoing); Cardiovalve: Equity Interest (Ongoing); Claret: Equity Interest (Ongoing); HighLife: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Imperative Care: Equity Interest (Ongoing); Jena Valve: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Laminar: Equity Interest (Ongoing); Medtronic: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Millipede: Equity Interest (Ongoing); Pi-Cardia: Equity Interest (Ongoing); Protembis: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Reniva Medical: Equity Interest (Ongoing); Shockwave: Equity Interest (Ongoing); Valve medical: Equity Interest (Ongoing)

• Novel TAVR Devices: An Update on Valves for Aortic Regurgitation

  Monday, February 27, 2023
  4:56 PM – 5:04 PM ET

  Disclosure(s): Ancora: Equity Interest (Ongoing); Boston Scientific: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); CardioMech: Equity Interest (Ongoing); Cardiovalve: Equity Interest (Ongoing); Claret: Equity Interest (Ongoing); HighLife: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Imperative Care: Equity Interest (Ongoing); Jena Valve: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Laminar: Equity Interest (Ongoing); Medtronic: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Millipede: Equity Interest (Ongoing); Pi-Cardia: Equity Interest (Ongoing); Protembis: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Reniva Medical: Equity Interest (Ongoing); Shockwave: Equity Interest (Ongoing); Valve medical: Equity Interest (Ongoing)

• Panel Discussion: Treatment of Aortic Insufficiency | The Next Frontier

  Monday, February 27, 2023
  3:47 PM – 4:10 PM ET

  Disclosure(s): Ancora: Equity Interest (Ongoing); Boston Scientific: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); CardioMech: Equity Interest (Ongoing); Cardiovalve: Equity Interest (Ongoing); Claret: Equity Interest (Ongoing); HighLife: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Imperative Care: Equity Interest (Ongoing); Jena Valve: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Laminar: Equity Interest (Ongoing); Medtronic: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Millipede: Equity Interest (Ongoing); Pi-Cardia: Equity Interest (Ongoing); Protembis: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Reniva Medical: Equity Interest (Ongoing); Shockwave: Equity Interest (Ongoing); Valve medical: Equity Interest (Ongoing)

• Panel Discussion | Can we Prevent Coronary Obstruction Post TAVR

  Tuesday, February 28, 2023
  8:32 AM – 8:58 AM ET

  Disclosure(s): Ancora: Equity Interest (Ongoing); Boston Scientific: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); CardioMech: Equity Interest (Ongoing); Cardiovalve: Equity Interest (Ongoing); Claret: Equity Interest (Ongoing); HighLife: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Imperative Care: Equity Interest (Ongoing); Jena Valve: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Laminar: Equity Interest (Ongoing); Medtronic: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Millipede: Equity Interest (Ongoing); Pi-Cardia: Equity Interest (Ongoing); Protembis: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Reniva Medical: Equity Interest (Ongoing); Shockwave: Equity Interest (Ongoing); Valve medical: Equity Interest (Ongoing)

• Can Scoring the Calcified Aortic Valve Defer the need for a Permanent Implant?

  Tuesday, February 28, 2023
  8:58 AM – 9:06 AM ET

  Disclosure(s): Ancora: Equity Interest (Ongoing); Boston Scientific: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); CardioMech: Equity Interest (Ongoing); Cardiovalve: Equity Interest (Ongoing); Claret: Equity Interest (Ongoing); HighLife: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Imperative Care: Equity Interest (Ongoing); Jena Valve: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Laminar: Equity Interest (Ongoing); Medtronic: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Millipede: Equity Interest (Ongoing); Pi-Cardia: Equity Interest (Ongoing); Protembis: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Reniva Medical: Equity Interest (Ongoing); Shockwave: Equity Interest (Ongoing); Valve medical: Equity Interest (Ongoing)

• Panel Discussion | Second- and Third-Generation Aortic Valve Systems not Approved in the US Yet

  Tuesday, February 28, 2023
  10:18 AM – 10:30 AM ET

  Disclosure(s): Ancora: Equity Interest (Ongoing); Boston Scientific: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); CardioMech: Equity Interest (Ongoing); Cardiovalve: Equity Interest (Ongoing); Claret: Equity Interest (Ongoing); HighLife: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Imperative Care: Equity Interest (Ongoing); Jena Valve: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Laminar: Equity Interest (Ongoing); Medtronic: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Millipede: Equity Interest (Ongoing); Pi-Cardia: Equity Interest (Ongoing); Protembis: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Reniva Medical: Equity Interest (Ongoing); Shockwave: Equity Interest (Ongoing); Valve medical: Equity Interest (Ongoing)

• Live Case from Ascension St. John Hospital | Detroit, MI

  Tuesday, February 28, 2023
  9:00 AM – 10:00 AM ET

  Disclosure(s): Ancora: Equity Interest (Ongoing); Boston Scientific: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); CardioMech: Equity Interest (Ongoing); Cardiovalve: Equity Interest (Ongoing); Claret: Equity Interest (Ongoing); HighLife: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Imperative Care: Equity Interest (Ongoing); Jena Valve: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Laminar: Equity Interest (Ongoing); Medtronic: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Millipede: Equity Interest (Ongoing); Pi-Cardia: Equity Interest (Ongoing); Protembis: Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Reniva Medical: Equity Interest (Ongoing); Shockwave: Equity Interest (Ongoing); Valve medical: Equity Interest (Ongoing)